Exodus Point Capital Management, LP Wave Life Sciences Ltd. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.14 - $5.15 $57,716 - $94,662	-18,381 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $238,617 - $347,434	-48,797 Reduced 72.64%	18,381 $90,000
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $379,555 - $501,819	67,178 New	67,178 $447,000
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $206,408 - $441,883	-36,793 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $454,308 - $601,844	-64,994 Reduced 63.85%	36,793 $290,000
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $467,153 - $1.08 Million	55,024 Added 117.67%	101,787 $864,000
Q2 2020 Aug 14, 2020	BUY	$7.44 - $11.29 $347,916 - $527,954	46,763 New	46,763 $487,000
Q3 2019 Nov 14, 2019	SELL	$19.17 - $27.4 $357,520 - $511,010	-18,650 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $427,644 - $798,966	18,650 New	18,650 $487,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.24B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.